311 related articles for article (PubMed ID: 22517429)
1. Proteasome inhibitor interacts synergistically with autophagy inhibitor to suppress proliferation and induce apoptosis in hepatocellular carcinoma.
Hui B; Shi YH; Ding ZB; Zhou J; Gu CY; Peng YF; Yang H; Liu WR; Shi GM; Fan J
Cancer; 2012 Nov; 118(22):5560-71. PubMed ID: 22517429
[TBL] [Abstract][Full Text] [Related]
2. An autophagy inhibitor enhances the inhibition of cell proliferation induced by a proteasome inhibitor in MCF-7 cells.
Yao F; Wang G; Wei W; Tu Y; Tong H; Sun S
Mol Med Rep; 2012 Jan; 5(1):84-8. PubMed ID: 21931937
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of autophagy induced by proteasome inhibition increases cell death in human SHG-44 glioma cells.
Ge PF; Zhang JZ; Wang XF; Meng FK; Li WC; Luan YX; Ling F; Luo YN
Acta Pharmacol Sin; 2009 Jul; 30(7):1046-52. PubMed ID: 19575007
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of autophagy enhances apoptosis induced by proteasome inhibitor bortezomib in human glioblastoma U87 and U251 cells.
Zhang X; Li W; Wang C; Leng X; Lian S; Feng J; Li J; Wang H
Mol Cell Biochem; 2014 Jan; 385(1-2):265-75. PubMed ID: 24104452
[TBL] [Abstract][Full Text] [Related]
5. Effect of inhibition of the ubiquitin-proteasome system and Hsp90 on growth and survival of rhabdomyosarcoma cells in vitro.
Peron M; Bonvini P; Rosolen A
BMC Cancer; 2012 Jun; 12():233. PubMed ID: 22691173
[TBL] [Abstract][Full Text] [Related]
6. Cancerous inhibitor of protein phosphatase 2A mediates bortezomib-induced autophagy in hepatocellular carcinoma independent of proteasome.
Yu HC; Hou DR; Liu CY; Lin CS; Shiau CW; Cheng AL; Chen KF
PLoS One; 2013; 8(2):e55705. PubMed ID: 23383345
[TBL] [Abstract][Full Text] [Related]
7. Novel synergistic antitumor effects of rapamycin with bortezomib on hepatocellular carcinoma cells and orthotopic tumor model.
Wang C; Gao D; Guo K; Kang X; Jiang K; Sun C; Li Y; Sun L; Shu H; Jin G; Sun H; Wu W; Liu Y
BMC Cancer; 2012 May; 12():166. PubMed ID: 22559167
[TBL] [Abstract][Full Text] [Related]
8. Effect of autophagy on multiple myeloma cell viability.
Hoang B; Benavides A; Shi Y; Frost P; Lichtenstein A
Mol Cancer Ther; 2009 Jul; 8(7):1974-84. PubMed ID: 19509276
[TBL] [Abstract][Full Text] [Related]
9. Beclin 1 enhances proteasome inhibition-mediated cytotoxicity of thyroid cancer cells in macroautophagy-independent manner.
Zhang HY; Du ZX; Meng X; Zong ZH; Wang HQ
J Clin Endocrinol Metab; 2013 Feb; 98(2):E217-26. PubMed ID: 23264393
[TBL] [Abstract][Full Text] [Related]
10. Bortezomib induces protective autophagy through AMP-activated protein kinase activation in cultured pancreatic and colorectal cancer cells.
Min H; Xu M; Chen ZR; Zhou JD; Huang M; Zheng K; Zou XP
Cancer Chemother Pharmacol; 2014 Jul; 74(1):167-76. PubMed ID: 24842158
[TBL] [Abstract][Full Text] [Related]
11. Antitumor effects of proteasome inhibition in anaplastic thyroid carcinoma.
Altmann A; Markert A; Askoxylakis V; Schöning T; Jesenofsky R; Eisenhut M; Haberkorn U
J Nucl Med; 2012 Nov; 53(11):1764-71. PubMed ID: 23055533
[TBL] [Abstract][Full Text] [Related]
12. Autophagy-independent enhancing effects of Beclin 1 on cytotoxicity of ovarian cancer cells mediated by proteasome inhibitors.
Liu C; Yan X; Wang HQ; Gao YY; Liu J; Hu Z; Liu D; Gao J; Lin B
BMC Cancer; 2012 Dec; 12():622. PubMed ID: 23270461
[TBL] [Abstract][Full Text] [Related]
13. 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes induce autophagic cell death in estrogen receptor negative breast cancer.
Vanderlaag K; Su Y; Frankel AE; Burghardt RC; Barhoumi R; Chadalapaka G; Jutooru I; Safe S
BMC Cancer; 2010 Dec; 10():669. PubMed ID: 21129193
[TBL] [Abstract][Full Text] [Related]
14. The GST-BHMT assay reveals a distinct mechanism underlying proteasome inhibition-induced macroautophagy in mammalian cells.
Rui YN; Xu Z; Chen Z; Zhang S
Autophagy; 2015; 11(5):812-32. PubMed ID: 25984893
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of phospho-Akt is a major molecular determinant of bortezomib-induced apoptosis in hepatocellular carcinoma cells.
Chen KF; Yeh PY; Yeh KH; Lu YS; Huang SY; Cheng AL
Cancer Res; 2008 Aug; 68(16):6698-707. PubMed ID: 18701494
[TBL] [Abstract][Full Text] [Related]
16. Bortezomib enhances cancer cell death by blocking the autophagic flux through stimulating ERK phosphorylation.
Kao C; Chao A; Tsai CL; Chuang WC; Huang WP; Chen GC; Lin CY; Wang TH; Wang HS; Lai CH
Cell Death Dis; 2014 Nov; 5(11):e1510. PubMed ID: 25375375
[TBL] [Abstract][Full Text] [Related]
17. Cooperative cytotoxicity of proteasome inhibitors and tumor necrosis factor-related apoptosis-inducing ligand in chemoresistant Bcl-2-overexpressing cells.
Nencioni A; Wille L; Dal Bello G; Boy D; Cirmena G; Wesselborg S; Belka C; Brossart P; Patrone F; Ballestrero A
Clin Cancer Res; 2005 Jun; 11(11):4259-65. PubMed ID: 15930365
[TBL] [Abstract][Full Text] [Related]
18. BAG3 induction is required to mitigate proteotoxicity via selective autophagy following inhibition of constitutive protein degradation pathways.
Rapino F; Jung M; Fulda S
Oncogene; 2014 Mar; 33(13):1713-24. PubMed ID: 23644654
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic synergy between the multikinase inhibitor sorafenib and the proteasome inhibitor bortezomib in vitro: induction of apoptosis through Akt and c-Jun NH2-terminal kinase pathways.
Yu C; Friday BB; Lai JP; Yang L; Sarkaria J; Kay NE; Carter CA; Roberts LR; Kaufmann SH; Adjei AA
Mol Cancer Ther; 2006 Sep; 5(9):2378-87. PubMed ID: 16985072
[TBL] [Abstract][Full Text] [Related]
20. Restoration of klotho expression induces apoptosis and autophagy in hepatocellular carcinoma cells.
Shu G; Xie B; Ren F; Liu DC; Zhou J; Li Q; Chen J; Yuan L; Zhou J
Cell Oncol (Dordr); 2013 Apr; 36(2):121-9. PubMed ID: 23248036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]